References
- Avanzini G, Franceschetti S. Cellular biology of epileptogenesis. Lancet NeuroL 2(1), 33–42 (2003).
- Pitkänen A, Sutula TP. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet NeuroL 1(3), 173–181 (2002).
- Stables JP, Bertram EH, White HS et al. Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, MD, USA. Epilepsia 43(11), 1410–1420 (2002).
- Stables JP, Bertram E, Dudek FE et al. Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIWNINDS/AES models II workshop. Epilepsia 44(12), 1472–1478 (2003).
- Pitkänen A. New pharmacotherapy for epilepsy. Drugs 7 (5), 471–477 (2004).
- Pitkänen A, Kubova H. Antiepileptic drugs in neuroprotection. Expert Opin. Pharmacother. 5(4), 777–798 (2004).
- Beghi E, Beghi M, Cornaggia C. Primary prevention of epilepsy in patients with different epileptogenic conditions. Expert Rev Neurotherapeutics 4 (6), 945–952 (2004).
- Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42 (4), 515–524 (2001).
- Noebels JL. The biology of epilepsy genes. Ann. Rev Neurosci. 26,599–625 (2003).
- Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann. NeuroL 44(6), 908–912 (1998).
- Kelly KM, Kharlamov A, Hentosz TM et al. Photothrombotic brain infarction results in seizure activity in aging Fischer 344 and Sprague Dawley rats. Epilepsy Res. 47(3), 189–203 (2001).
- Kharatishvili I, Nissinen J, Mcintosh TK, Pitkänen A. A rat model for head trauma induced epileptogenesis in humans. Epilepsia 44\(Suppl. 8), 36 (2003).
- Bezvenyuk Z, Nissinen J, Pitkänen A. Photothrombotic brain infarction induced epileptogenesis in rats. Soc. Neurosci. Abst. 533,15 (2003).
- D'Ambrosio R, Fairbanks JP, Fender JS, Born DE, Doyle DL, Miller JW. Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 127\(Pt 2), 304–314 (2004).
- Pitkänen A, Narkilahti S, Bezvenyuk Z, Haapalinna A, Nissinen J. Atipamezole, an ia(2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats. Epilepsy Res. 61(1–3), 119–140 (2004).
- Brandt C, Potschka H, Loscher W, Ebert U. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118(3), 727–740 (2003).
- Lukasiuk K, Pitkänen A. Large-scale analysis of gene expression in epilepsy research: is synthesis already possible? Neurochem. Res. 29(6), 1169–1178 (2004).
- Royo NC, Shimizu S, Schouten JW, Stover JF, McIntosh TK. Pharmacology of traumatic brain injury. CUIT: Opin. Pharmacol. 3(1), 27–32 (2003).
- Royo NC, Schouten JW, Fulp CT et al. From cell death to neuronal regeneration: building a new brain after traumatic brain injury. I Neuropathol. Exp. Neurol. 62(8), 801–811 (2003).
Websites
- World Health Organization www.who.intimediacentrafactsheetsi fs165/eni (Accessed October 2004)